Internal Medicine Doctors in Idaho Falls, ID Accepting Medicare

46 Internal Medicine doctors found. Showing 41 - 46

Mr. Douglas U. Blank, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2985 Cortez Ave, Idaho Falls, ID 83404 Phone: 208-523-3373    Fax: 208-523-8746

Dr. Nathan Bradley Adams, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2330 Desoto St, Idaho Falls, ID 83404 Phone: 208-523-1100    Fax: 208-523-1317

Dr. David Redford Liljenquist, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3910 Washington Parkway, Idaho Falls, ID 83404 Phone: 208-523-1122    Fax: 208-523-2582

Cory Spicer, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2265 E Sunnyside Rd, Idaho Falls, ID 83404 Phone: 208-542-5000    Fax: 208-542-5151

Dr. Richard Alan Nathan, D.O. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3614 Washington Pkwy, Idaho Falls, ID 83404 Phone: 208-535-8400    Fax: 208-535-8409

Joyce Lynette Sanchez, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3200 Channing Way Ste 306, Idaho Falls, ID 83404 Phone: 208-535-4475    Fax: 208-535-4479

News Archive

Orthovita publishes clinical data from IDE pilot studies

Orthovita, Inc., an orthobiologics and biosurgery company, is pleased to announce the publication of "Clinical Experience Using Cortoss for Treating Vertebral Compression Fractures with Vertebroplasty and Kyphoplasty" in the September 15, 2010 edition of Spine.

Vaginal delivery for preterm vertex babies not as risky as thought

Vaginal delivery for early preterm infants who have a vertex presentation does not have a significant negative impact on neonatal mortality compared with cesarean delivery, research suggests.

New DNA-based test could better predict treatment outcomes for prostate cancer patients

Researchers at The Ontario Institute for Cancer Research and University Health Network, have identified a new DNA-based test that could be used to better predict how prostate cancer patients will respond to treatment and to prevent relapse.

Incept BioSystems commences human clinical trial of its SMART Embryo Culture System

Incept BioSystems, Inc., a privately-held biomedical device company using patented microfluidic technology developed at the University of Michigan, announced today that it has initiated the first U.S. human clinical trial of its proprietary SMART Embryo Culture System. The microscale SMART technology platform is designed to improve the in vitro manipulation, performance, and viability of embryos for the treatment of patients undergoing in vitro fertilization (IVF).

Health care professionals urge Congress to support nation's chemical regulatory reform

On the eve of legislation slated to be introduced this month to reform the Toxic Substances Control Act, almost two dozen organizations representing health care professionals, along with health sector businesses sent letters to Congress urging the passage of strong reform of our nation's chemical regulatory system.

Read more Medical News

› Verified 3 days ago

• 1
• 2
• 3(current)